298 Multidisciplinary maximum effort cyto-reductive surgery (MES) for advanced ovarian cancer in leicester: outcomes. (18th September 2019)
- Record Type:
- Journal Article
- Title:
- 298 Multidisciplinary maximum effort cyto-reductive surgery (MES) for advanced ovarian cancer in leicester: outcomes. (18th September 2019)
- Main Title:
- 298 Multidisciplinary maximum effort cyto-reductive surgery (MES) for advanced ovarian cancer in leicester: outcomes
- Authors:
- Ismail, A
Ofinran, O
Davies, Q
Moss, E
Bharathan, R
Boyle, K
Thomas, M
Malde, D
Bhardwaj, N
Camacho, E
Chattopadhyay, S - Abstract:
- Abstract : Objectives: It is recognised that adequate debulking in ovarian cancer surgeries does improve the survival rate; In Leicester, we have implemented a structured multidisciplinary surgical approach to offer Maximum effort surgery (MES) to our patients with advanced ovarian cancer. The surgical team includes gynae-oncologists, hepatobiliary/colorectal surgeons, and anaesthetic team. This approach has helped us develop effective skills in extensive complex abdominal surgeries, and optimising the intraoperative decision making, hence improving the outcomes. Methods: A retrospective evaluation of prospectively collected data was performed to assess the surgical outcomes of all consecutive patients who underwent ultra-radical surgery for advanced ovarian cancer, from January 2016 to February 2019. Results: 39 consecutive women had MES. Median age was 65(range 27–86). 19(49%) had PDS and 18(46%) had IDS while 2(5%) had secondary cytoreduction. The majority of the patients were stage IIIC or above (92%) and most were high grade serous histology (85%). The median surgical duration was 297 minutes. Complete cytoreduction with no gross residual disease (GRD) was achieved in 87% of the patients, 8% had GRD <1cm and only 5% had suboptimal cytoreduction. Median blood loss was 800mls. Median length of hospital stay was 9 days. One patient died in the first 28 days post-surgery. The postoperative complications are presented in table 1 using the Clavien-Dindo classification.Abstract : Objectives: It is recognised that adequate debulking in ovarian cancer surgeries does improve the survival rate; In Leicester, we have implemented a structured multidisciplinary surgical approach to offer Maximum effort surgery (MES) to our patients with advanced ovarian cancer. The surgical team includes gynae-oncologists, hepatobiliary/colorectal surgeons, and anaesthetic team. This approach has helped us develop effective skills in extensive complex abdominal surgeries, and optimising the intraoperative decision making, hence improving the outcomes. Methods: A retrospective evaluation of prospectively collected data was performed to assess the surgical outcomes of all consecutive patients who underwent ultra-radical surgery for advanced ovarian cancer, from January 2016 to February 2019. Results: 39 consecutive women had MES. Median age was 65(range 27–86). 19(49%) had PDS and 18(46%) had IDS while 2(5%) had secondary cytoreduction. The majority of the patients were stage IIIC or above (92%) and most were high grade serous histology (85%). The median surgical duration was 297 minutes. Complete cytoreduction with no gross residual disease (GRD) was achieved in 87% of the patients, 8% had GRD <1cm and only 5% had suboptimal cytoreduction. Median blood loss was 800mls. Median length of hospital stay was 9 days. One patient died in the first 28 days post-surgery. The postoperative complications are presented in table 1 using the Clavien-Dindo classification. Conclusions: Our data favours a multidisciplinary structured MES service for advanced ovarian cancer and this could be a more effective approach than a unidisciplinary approach. It minimises the morbidity, enables the development interdisciplinary surgical skills and improves the quality of surgery. … (more)
- Is Part Of:
- International journal of gynecological cancer. Volume 29(2019)Supplement 3
- Journal:
- International journal of gynecological cancer
- Issue:
- Volume 29(2019)Supplement 3
- Issue Display:
- Volume 29, Issue 3 (2019)
- Year:
- 2019
- Volume:
- 29
- Issue:
- 3
- Issue Sort Value:
- 2019-0029-0003-0000
- Page Start:
- A124
- Page End:
- A125
- Publication Date:
- 2019-09-18
- Subjects:
- Generative organs, Female -- Cancer -- Periodicals
616.99465 - Journal URLs:
- http://journals.lww.com/ijgc/pages/default.aspx ↗
http://www3.interscience.wiley.com/journal/118544021/toc ↗
https://ijgc.bmj.com/ ↗
http://journals.lww.com ↗ - DOI:
- 10.1136/ijgc-2019-IGCS.298 ↗
- Languages:
- English
- ISSNs:
- 1048-891X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4542.273500
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 19724.xml